Device and method for preventing stenosis at an anastomosis site
AssigneeVascular Therapies, LLC
InventorsSriram Iyer, Gerald Dorros
Life of this patent
Estimating the term…
Loading patent…
AssigneeVascular Therapies, LLC
InventorsSriram Iyer, Gerald Dorros
Estimating the term…
The present invention relates to treating or preventing stenosis at an anastomosis site. In one embodiment, the present invention is a stent is curved along the longitudinal axis for placement in and adjacent to the graft orifice. In a further embodiment, the stent is drug coated to allow delivery of antivasculoproliferative drugs directly to the vicinity of the graft orifice. In a further embodiment, the stent is expandable by use of an external wire. In another embodiment, the present invention is a kit comprising the specially configured stent together with a sleeve comprising a biocompatible matrix material and a pharmaceutical agent, wherein the sleeve is applied to the external surface of the vessel or graft, resulting in extravascular delivery of a pharmaceutical agent. Methods for treating or preventing stenosis at an anastomosis site by applying the extravascular sleeve and the intravascular stent are also provided.
A method for preventing or treating stenosis in a vascular structure having an anastomosis comprising deploying a drug free stent within the lumen of a vascular structure and applying locally and externally to the vascular structure, a biocompatible matrix material that carries an anti-vasculoproliferative drug and is free of biological cells, wherein the anastomosis is a part of an artery, vein or graft.
A method for preventing or treating stenosis at an anastomosis site comprising deploying a drug free stent within the lumen of a blood vessel and wrapping the exterior surface of the blood vessel with a biocompatible matrix material that carries an anti-vasculoproliferative drug and is free of biological cells.
A method for preventing or treating stenosis in a vascular structure having an anastomosis comprising deploying a drug free stent within the lumen of a vascular structure and applying locally and externally to the vascular structure a sleeve consisting essentially of a biocompatible matrix material and an anti-vasculoproliferative drug, wherein the anastomosis is a part of an artery, vein or graft.
Dependencies are inferred from the claim text.